{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T11:51:41Z","timestamp":1724413901546},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"27","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1097\/md.0000000000004130","type":"journal-article","created":{"date-parts":[[2016,7,8]],"date-time":"2016-07-08T16:35:39Z","timestamp":1467995739000},"page":"e4130","source":"Crossref","is-referenced-by-count":3,"title":["Stent thrombosis and adverse cardiovascular outcomes observed between six months and five years with sirolimus-eluting stents and other drug-eluting stents in patients with Type 2 diabetes mellitus complicated by coronary artery disease"],"prefix":"10.1097","volume":"95","author":[{"given":"Pravesh Kumar","family":"Bundhun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Zafooruddin Sani","family":"Soogund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manish","family":"Pursun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng-Hua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-69-20210226","first-page":"31","article-title":"Diabetes and Adverse Cardiovascular Outcomes in Patients with Acute Coronary Syndrome - Data from Taiwan's Acute Coronary Syndrome Full Spectrum Data Registry","volume":"32","author":"Wei","year":"2016","journal-title":"Zhonghua Minguo Xin Zang Xue Hui Za Zhi"},{"key":"R2-69-20210226","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0300-8932(09)70892-9","article-title":"Drug-eluting stents versus bare-metal stents in diabetic patients with ST-segment elevation acute myocardial infarction: a pooled analysis of individual patient data from seven randomized trials","volume":"62","author":"Iijima","year":"2009","journal-title":"Rev Esp Cardiol"},{"key":"R3-69-20210226","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.2337\/dc12-1507","article-title":"Impact of diabetes on long-term outcome after primary angioplasty: insights from the DESERT cooperation","volume":"36","author":"De Luca","year":"2013","journal-title":"Diabetes Care"},{"key":"R4-69-20210226","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jacc.2008.04.056","article-title":"A randomized comparison of sirolimus- versus paclitaxel-eluting stent implantation in patients with diabetes mellitus","volume":"52","author":"Lee","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R5-69-20210226","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.amjcard.2005.03.075","article-title":"Comparison of short- (one month) and long- (twelve months) term outcomes of sirolimus- versus paclitaxel-eluting stents in 293 consecutive patients with diabetes mellitus (from the RESEARCH and T-SEARCH registries)","volume":"96","author":"Ong","year":"2005","journal-title":"Am J Cardiol"},{"key":"R6-69-20210226","doi-asserted-by":"crossref","first-page":"e3276","DOI":"10.1097\/MD.0000000000003276","article-title":"Are everolimus-eluting stents associated with better clinical outcomes compared to other drug-eluting stents in patients with type 2 diabetes mellitus?: A systematic review and meta-analysis","volume":"95","author":"Bundhun","year":"2016","journal-title":"Medicine (Baltimore"},{"key":"R7-69-20210226","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1161\/CIRCINTERVENTIONS.111.963256","article-title":"Everolimus-eluting versus sirolimus-eluting stents: a meta-analysis of randomized trials","volume":"4","author":"de Waha A","year":"2011","journal-title":"Circ Cardiovasc Interv"},{"key":"R8-69-20210226","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"R10-69-20210226","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"R11-69-20210226","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/eurheartj\/ehn021","article-title":"Two-year clinical outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents in diabetic patients","volume":"29","author":"Billinger","year":"2008","journal-title":"Eur Heart J"},{"key":"R12-69-20210226","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1161\/CIRCINTERVENTIONS.110.959924","article-title":"Novel approaches for preventing or limiting events in diabetic patients (Naples-diabetes) trial: a randomized comparison of 3 drug-eluting stents in diabetic patients","volume":"4","author":"Briguori","year":"2011","journal-title":"Circ Cardiovasc Interv"},{"key":"R13-69-20210226","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.amjcard.2007.12.021","article-title":"Outcomes after sirolimus- and paclitaxel-eluting stent implantation in patients with insulin-treated diabetes mellitus","volume":"101","author":"Buch","year":"2008","journal-title":"Am J Cardiol"},{"key":"R14-69-20210226","doi-asserted-by":"crossref","first-page":"381","DOI":"10.47102\/annals-acadmedsg.V39N5p381","article-title":"Eighteen-month clinical safety and efficacy outcomes of sirolimus-, paclitaxel- and zotarolimus-drug eluting stents in diabetic patients undergoing percutaneous coronary intervention for complex coronary artery stenosis","volume":"39","author":"Chong","year":"2010","journal-title":"Ann Acad Med Singapore"},{"key":"R15-69-20210226","first-page":"404","article-title":"Drug-eluting stents in the elderly: long-term (>one year) clinical outcomes of octogenarians in the DESIRE (Drug-Eluting Stents In the REal world) registry","volume":"20","author":"Costa","year":"2008","journal-title":"J Invasive Cardiol"},{"key":"R16-69-20210226","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.jcin.2010.11.016","article-title":"Randomized comparison of a polymer-free sirolimus-eluting stent versus a polymer-based paclitaxel-eluting stent in patients with diabetes mellitus: the LIPSIA Yukon trial","volume":"4","author":"Desch","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"key":"R18-69-20210226","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.amjcard.2012.07.022","article-title":"Comparison of outcomes in patients with versus without diabetes mellitus after revascularization with everolimus- and sirolimus-eluting stents (from the SORT OUT IV trial)","volume":"110","author":"Jensen","year":"2012","journal-title":"Am J Cardiol"},{"key":"R19-69-20210226","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.jcin.2012.06.020","article-title":"Clinical impact of second-generation everolimus-eluting stent compared with first-generation drug-eluting stents in diabetes mellitus patients: insights from a nationwide coronary intervention register","volume":"5","author":"Kedhi","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"key":"R20-69-20210226","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/ccd.21700","article-title":"Comparison of sirolimus-eluting stent and paclitaxel-eluting stent for long-term cardiac adverse events in diabetic patients: the Korean Multicenter Angioplasty Team (KOMATE) Registry","volume":"72","author":"Kim","year":"2008","journal-title":"Catheter Cardiovasc Interv"},{"key":"R21-69-20210226","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1161\/CIRCULATIONAHA.110.015453","article-title":"Randomized comparison of everolimus-eluting stent versus sirolimus-eluting stent implantation for de novo coronary artery disease in patients with diabetes mellitus (ESSENCE-DIABETES): results from the ESSENCE-DIABETES trial","volume":"124","author":"Kim","year":"2011","journal-title":"Circulation"},{"key":"R22-69-20210226","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.amjcard.2006.01.074","article-title":"Sirolimus-eluting stents versus paclitaxel-eluting stents in the treatment of coronary artery disease in patients with diabetes mellitus","volume":"98","author":"Kuchulakanti","year":"2006","journal-title":"Am J Cardiol"},{"key":"R23-69-20210226","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.carrev.2014.02.001","article-title":"Sirolimus-eluting versus paclitaxel-eluting stents in diabetic and non-diabetic patients within sirolimus-eluting stent restenosis: results from the ISAR-DESIRE 2 trial","volume":"15","author":"Kufner","year":"2014","journal-title":"Cardiovasc Revasc Med"},{"key":"R24-69-20210226","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jcin.2010.12.006","article-title":"A randomized comparison of sirolimus- versus paclitaxel-eluting stent implantation in patients with diabetes mellitus: 4-year clinical outcomes of DES-DIABETES (drug-eluting stent in patients with DIABETES mellitus) trial","volume":"4","author":"Lee","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"key":"R25-69-20210226","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.amjcard.2008.09.084","article-title":"Comparison of the sirolimus-eluting versus paclitaxel-eluting coronary stent in patients with diabetes mellitus: the diabetes and drug-eluting stent (DiabeDES) randomized angiography trial","volume":"103","author":"Maeng","year":"2009","journal-title":"Am J Cardiol"},{"key":"R26-69-20210226","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1002\/ccd.25875","article-title":"A 10-month angiographic and 4-year clinical outcome of everolimus-eluting versus sirolimus-eluting coronary stents in patients with diabetes mellitus (the DiabeDES IV randomized angiography trial)","volume":"86","author":"Maeng","year":"2015","journal-title":"Catheter Cardiovasc Interv"},{"key":"R27-69-20210226","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ijcard.2016.01.023","article-title":"Three-year follow-up outcomes of SES and PES in a randomized controlled study stratified by the presence of diabetes mellitus: J-DEsSERT trial","volume":"208","author":"Nakamura","year":"2016","journal-title":"Int J Cardiol"},{"key":"R28-69-20210226","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.amjcard.2014.10.038","article-title":"Long-term outcome of sirolimus-eluting and zotarolimus-eluting coronary stent implantation in patients with and without diabetes mellitus (a Danish organization for randomized trials on clinical outcome III substudy)","volume":"115","author":"Olesen","year":"2015","journal-title":"Am J Cardiol"},{"key":"R29-69-20210226","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ijcard.2013.10.006","article-title":"Long-term outcome of the unrestricted use of everolimus-eluting stents compared to sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients: the Bern-Rotterdam diabetes cohort study","volume":"170","author":"Simsek","year":"2013","journal-title":"Int J Cardiol"},{"key":"R30-69-20210226","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.amjcard.2006.01.104","article-title":"Impact of sirolimus-eluting and paclitaxel-eluting stents on outcome in patients with diabetes mellitus and stenting in more than one coronary artery","volume":"98","author":"Stankovic","year":"2006","journal-title":"Am J Cardiol"},{"key":"R31-69-20210226","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1161\/CIRCINTERVENTIONS.109.885996","article-title":"Paclitaxel-eluting versus sirolimus-eluting stents in diabetes mellitus: a report from the National Heart, Lung, and Blood Institute Dynamic Registry","volume":"3","author":"Wolf","year":"2010","journal-title":"Circ Cardiovasc Interv"},{"key":"R32-69-20210226","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1161\/CIRCOUTCOMES.108.826057","article-title":"Paclitaxel versus sirolimus stents in diabetic and nondiabetic patients","volume":"2","author":"Chiu","year":"2009","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"R33-69-20210226","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/eurheartj\/ehl412","article-title":"The long-term value of sirolimus- and paclitaxel-eluting stents over bare metal stents in patients with diabetes mellitus","volume":"28","author":"Daemen","year":"2007","journal-title":"Eur Heart J"},{"key":"R34-69-20210226","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/ccd.24603","article-title":"Differential long-term outcomes of zotarolimus-eluting stents compared with sirolimus-eluting and paclitaxel-eluting stents in diabetic and nondiabetic patients: two-year subgroup analysis of the ZEST randomized trial","volume":"81","author":"Jang","year":"2013","journal-title":"Catheter Cardiovasc Interv"},{"key":"R35-69-20210226","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jjcc.2012.07.002","article-title":"Differences in clinical and angiographic outcomes with different drug-eluting stents in Japanese patients with and without diabetes mellitus","volume":"60","author":"Sato","year":"2012","journal-title":"J Cardiol"},{"key":"R36-69-20210226","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/ccd.22293","article-title":"Comparison of 2-year clinical outcomes with sirolimus and paclitaxel-eluting stents for patients with diabetes: results of the Registro Regionale AngiopLastiche Emilia-Romagna Registry","volume":"75","author":"Balducelli","year":"2010","journal-title":"Catheter Cardiovasc Interv"},{"key":"R37-69-20210226","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/ccd.24636","article-title":"Paclitaxel- and sirolimus-eluting stents in older patients with diabetes mellitus: results of a real-life multicenter registry","volume":"81","author":"Buja","year":"2013","journal-title":"Catheter Cardiovasc Interv"},{"key":"R38-69-20210226","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/MCA.0b013e3283650210","article-title":"Comparison of clinical outcomes between first-generation and second-generation drug-eluting stents in type 2 diabetic patients","volume":"24","author":"Jeong","year":"2013","journal-title":"Coron Artery Dis"},{"key":"R39-69-20210226","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1540-8183.2008.00353.x","article-title":"Effect of paclitaxel-eluting versus sirolimus-eluting stents on coronary restenosis in Korean diabetic patients","volume":"21","author":"Kim","year":"2008","journal-title":"J Interv Cardiol"},{"key":"R40-69-20210226","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1016\/j.jacc.2008.03.028","article-title":"Clinical efficacy of drug-eluting stents in diabetic patients: a meta-analysis","volume":"51","author":"Mahmud","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R41-69-20210226","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.ahj.2011.07.003","article-title":"A meta-analysis of specifically designed randomized trials of sirolimus-eluting versus paclitaxel-eluting stents in diabetic patients with coronary artery disease","volume":"162","author":"Kufner","year":"2011","journal-title":"Am Heart J"},{"key":"R42-69-20210226","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.amjcard.2009.08.652","article-title":"Meta-analysis of five randomized clinical trials comparing sirolimus- versus paclitaxel-eluting stents in patients with diabetes mellitus","volume":"105","author":"Zhang","year":"2010","journal-title":"Am J Cardiol"},{"key":"R43-69-20210226","doi-asserted-by":"crossref","first-page":"213","DOI":"10.5114\/aoms.2014.42571","article-title":"Second- versus first-generation drug-eluting stents for diabetic patients: a meta-analysis","volume":"10","author":"Yan","year":"2014","journal-title":"Arch Med Sci"},{"key":"R44-69-20210226","doi-asserted-by":"crossref","first-page":"e5170","DOI":"10.1136\/bmj.e5170","article-title":"Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22,844 patient years of follow-up from randomised trials","volume":"345","author":"Bangalore","year":"2012","journal-title":"BMJ"},{"key":"R45-69-20210226","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.amjcard.2011.06.037","article-title":"Outcome of sirolimus-eluting versus zotarolimus-eluting coronary stent implantation in patients with and without diabetes mellitus (a SORT OUT III substudy)","volume":"108","author":"Maeng","year":"2011","journal-title":"Am J Cardiol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000004130","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T04:52:43Z","timestamp":1718686363000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201607050-00069"}},"subtitle":["A systematic review and meta-analysis"],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":43,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000004130","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]}}}